Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07577908

Analgesic Efficiency of SIPSPB vs ICNB in VATS Surgery

This study aims to evaluate the effectiveness of Serratus Posterior Superior Intercostal Plane (SPSIP) block compared to Intercostal Nerve (ICN) block in terms of postoperative pain control, reduction of opioid analgesic consumption, minimization of postoperative respiratory complications, and increase patient satisfaction (using a 5-point Likert scale) in patients undergoing video-assisted thoracoscopic surgery (VATS).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kocaeli City Hospital

İzmit, Turkey (Türkiye)

Location status: Recruiting

Location contact

Ayşe Z Turan Cıvraz, Assoc. Prof.

CONTACT

[email protected]

+905054695850

About this study

In this prospective observational study, patients included in the study will receive Serratus Posterior Superior Intercostal Plane (SPSIP) block and Intercostal Nerve (ICN) block for postoperative analgesia at the end of surgery. The SPSIP block will be performed by the anesthesiologist under ultrasound guidance immediately after skin closure and before extubation, while the ICN block will be performed by the surgeon under direct vision immediately before skin closure.

At the end of surgery, patients will receive 1000 mg paracetamol and 50 mg dexketoprofen during skin closure. Upon arrival at the recovery room, each patient will be connected to a patient-controlled analgesia (PCA) pump containing tramadol. At postoperative reassessment, patients with a Numerical Pain Rating Scale (NPRS) score greater than 4 despite PCA use will receive a rescue analgesic dose of 50 mg dexketoprofen.

Postoperative pain intensity will be assessed using the NPRS (Numerical Pain Rating Scale) at 1, 4, 6, 12, 18, and 24 hours postoperatively, both at rest and during coughing. Total opioid consumption, rescue analgesic use, and postoperative complications will be recorded.

Patients will be informed about their level of surgical satisfaction 24 hours after surgery, and this information will be recorded.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18-80 years,
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Patients who have provided informed consent to participate in the study

Exclusion criteria

  • Patients who refuse to participate in the study by not signing the informed consent
  • Patients classified as ASA > 3, according to the system established by the American Society of Anesthesiologists
  • Patients unable to understand the use of the NPR Scale or the PCA device that will be used for postoperative analgesia
  • Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
  • Patients with allergies to analgesic and/or anesthetic drugs
  • Infection at the block injection site
  • Patients whose surgical procedure is intraoperatively converted to an open pulmonary resection

Treatment and study plan

Primary outcomes

  1. Postoperative pain intensity

    Time frame: 24 hours after the end of surgery

    In both study groups, postoperative pain intensity at rest and with coughing was measured using the Numerical Pain Rating Scale (NPRS), a numerical scale ranging from 0 to 10 (0 meaning no pain, 10 meaning the most severe pain imaginable).

Secondary outcomes

  1. Total opioid drug consumption

    Time frame: 24 hours after the end of surgery

    The total amount of opioid doses administered via a Patient Controlled Analgesia (PCA) device in the first 24 hours after surgery

  2. Consumption of rescue analgesics

    Time frame: 24 hours after the end of surgery

    The total dose of dexketoprofen required by the patient during each specified time interval in the first 24 hours after surgery.

  3. Postoperative Complications

    Time frame: 24 hours after the end of surgery

    Postoperative complications such as nausea, vomiting or other adverse events will be recorded

  4. Patient satisfaction score

    Time frame: At the 24th hour post-operation

    evaluated using a 5-point Likert scale (1=very dissatisfied, 5=very satisfied)

Study contacts

Contact information is provided by the study sponsor or research team.

Abdullah Bozkurt

CONTACT

[email protected]

+905369985015

Sponsors and collaborators

Lead sponsor

Kocaeli City Hospital

Other Gov

Registry information

Official study title

Comparison Of The Analgesic Effectiveness Of Ultrasonography-Guided Serratus Posterıor Superior Intercostal Plane (SPSIP) Block And Intercostal Nerve (ICN) Block In Video-Assisted Thoracoscopic Surgery Patients

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 11, 2026
Registry last updated
May 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.